IgA Vasculitis Triggered by Infective Endocarditis of Pulmonary Artery with Congenitally Corrected Transposition of the Great Arteries

  • Akagi Midori
    Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center Department of Rheumatology, JCHO Isahaya General Hospital
  • Iwanaga Nozomi
    Department of Rheumatology, National Hospital Organization Nagasaki Medical Center
  • Torisu Yuichi
    Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center
  • Fujita Hisayuki
    Physiological Laboratory, National Hospital Organization Nagasaki Medical Center
  • Kawahara Chieko
    Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center
  • Horai Yoshiro
    Department of Rheumatology, National Hospital Organization Nagasaki Medical Center Clinical Research Center, National Hospital Organization Nagasaki Medical Center
  • Izumi Yasumori
    Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center
  • Kawakami Atsushi
    Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences

書誌事項

タイトル別名
  • A Case Report and Literature Review

説明

<p>A man in his 40s with a history of congenitally corrected transposition of the great arteries (CCTGA) and closure of ventricular septal defect was referred to our hospital with purpura and hematuria. Presence of purpura, renal damage, and pathological findings on skin biopsy led to the diagnosis of IgA vasculitis (IgAV). Oral prednisolone (PSL) was initiated. However, Streptococcus pseudoporcinus was isolated from blood cultures, and transthoracic echocardiogram revealed vegetation on the pulmonary valve. From these findings, the diagnosis of infective endocarditis (IE) was made. Although the patient's condition improved after PSL interruption and antibiotic administration, his purpura relapsed. PSL readministration improved symptoms, with no further relapse even after gradual PSL dose reduction. The present case raises awareness of the importance of recognizing the occurrence of IE in IgAV patients, especially in those with congenital heart disease. CCTGA should be acknowledged as a risk factor for IE in the right-sided heart.</p>

収録刊行物

  • International Heart Journal

    International Heart Journal 61 (2), 404-408, 2020-03-28

    一般社団法人 インターナショナル・ハート・ジャーナル刊行会

参考文献 (18)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ